Last reviewed · How we verify
Staphylococcal infectious disease
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Nallpen In Plastic Container · Pfizer
- Vancocin · ANI Pharmaceuticals
- Nallpen In Plastic Container · Pfizer
- Lincocin · Pfizer
- Bactocill In Plastic Container · Apothecon
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Staphylococcal infectious disease patent landscape — cliff calendar, originator estates, attackable patents
- Staphylococcal infectious disease treatment landscape brief
- Staphylococcal infectious disease treatment updates RSS
Frequently asked questions about Staphylococcal infectious disease
What drugs treat Staphylococcal infectious disease?
Tracked treatments include Ramycin, Nallpen In Plastic Container, Vancocin, Lincocin, Bactocill In Plastic Container.
What is the treatment for Staphylococcal infectious disease?
Standard treatment for Staphylococcal infectious disease includes Ramycin, Nallpen In Plastic Container, Vancocin, Lincocin, Bactocill In Plastic Container. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Staphylococcal infectious disease patent cliff · Staphylococcal infectious disease CI report
- Treatment: Ramycin
- Treatment: Nallpen In Plastic Container · Pfizer
- Treatment: Vancocin · ANI Pharmaceuticals
- Treatment: Nallpen In Plastic Container · Pfizer
- Treatment: Lincocin · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing